brentuximab vedotin
seagen,takeda
['lymphoma']
stephen ansell presenting an updated analysis of the #echelon-1 &gt; aavd had better pfs &amp; os compared to abvd in untreated advanced-stage hl. fewer second malignancies in aavd arm. #asco22 #lymphoma 
Assist-Prof of Med, @MayoClinic FL, #ASCOTEC, ASCO AMEC. #Lymphoma #PTCL #CTCL #histiocyticDiseases #ClinicalResearch ?????? ????? ?? ?????? #???????